Sarepta Therapeutics, Inc.

Q2 2017 13F Holders

Symbol
SRPT
CUSIP
803607100
Type
Equity
Class
COM
Num filings
224
Total reported value, excl. options
$1.44 B
Manager Report Date Value ($000) Shares Option Type